Vav: function and regulation in hematopoietic cell signaling
- PMID: 8724692
- DOI: 10.1002/stem.140250
Vav: function and regulation in hematopoietic cell signaling
Abstract
Vav, a 95 kDa proto-oncogene product expressed specifically in hematopoietic cells, was originally isolated as a transforming human oncogene. Vav contains an array of functional domains that are involved in interactions with other proteins and, possibly, with lipids. These include, among others, a putative guanine nucleotide exchange domain, a cysteine-rich region similar to the phorbol ester/diacylglycerol-binding domain of protein kinase C, a pleckstrin-homology domain, and Src-homology 2 and 3 (SH2 and SH3, respectively) domains. The presence of these domains, the transforming activity of the vav oncogene, and the rapid increase in tyrosine phosphorylation of Vav induced by triggering of diverse receptors indicate that it plays an important role in hematopoietic cell signaling pathways. Such a role is supported by recent studies using "knockout" mice and transiently transfected T cells, in which Vav deletion or overexpression, respectively, had marked effects on lymphocyte development or activation. The presence of a putative guanine nucleotide exchange domain, the prototype of which is found in the dbl oncogene product, implies that Vav functions as a guanine nucleotide exchange factor (GEF) for one (or more) members of the Ras-like family of small GTP-binding proteins. In support of such a role, Vav preparations were found in some (but not other) studies to mediate in vitro-specific GEF activity for Ras. Additional studies are required to identify the physiological regulators and targets of Vav, and its exact role in hematopoietic cell development and signaling.
Similar articles
-
Vav: a potential link between tyrosine kinases and ras-like GTPases in hematopoietic cell signaling.Bioessays. 1993 Mar;15(3):179-83. doi: 10.1002/bies.950150306. Bioessays. 1993. PMID: 8489524 Review.
-
Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor.Oncogene. 1994 Aug;9(8):2405-13. Oncogene. 1994. PMID: 8036025
-
Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav.Oncogene. 1996 Aug 1;13(3):455-60. Oncogene. 1996. PMID: 8760286
-
Insulin-like growth factor-1 induces rapid tyrosine phosphorylation of the vav proto-oncogene product.Exp Hematol. 1996 Apr;24(5):622-7. Exp Hematol. 1996. PMID: 8605967
-
Vav: Captain Hook for signal transduction?Crit Rev Oncog. 1995;6(2):87-97. Crit Rev Oncog. 1995. PMID: 8792085 Review.
Cited by
-
Regulation of eIF4E guides a unique translational program to control erythroid maturation.Sci Adv. 2022 Dec 23;8(51):eadd3942. doi: 10.1126/sciadv.add3942. Epub 2022 Dec 23. Sci Adv. 2022. PMID: 36563140 Free PMC article.
-
Pleiotropic contributions of phospholipase C-gamma1 (PLC-gamma1) to T-cell antigen receptor-mediated signaling: reconstitution studies of a PLC-gamma1-deficient Jurkat T-cell line.Mol Cell Biol. 2000 Dec;20(24):9149-61. doi: 10.1128/MCB.20.24.9149-9161.2000. Mol Cell Biol. 2000. PMID: 11094067 Free PMC article.
-
Rac signaling in breast cancer: a tale of GEFs and GAPs.Cell Signal. 2012 Feb;24(2):353-362. doi: 10.1016/j.cellsig.2011.08.011. Epub 2011 Aug 27. Cell Signal. 2012. PMID: 21893191 Free PMC article. Review.
-
RhoA G17E/Vav1 Signaling Induces Cancer Invasion via Matrix Metalloproteinase-9 in Gastric Cancer.Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338221146024. doi: 10.1177/15330338221146024. Technol Cancer Res Treat. 2023. PMID: 36617975 Free PMC article.
-
Discovery of an unconventional lamprey lymphocyte lineage highlights divergent features in vertebrate adaptive immune system evolution.Nat Commun. 2024 Sep 3;15(1):7626. doi: 10.1038/s41467-024-51763-2. Nat Commun. 2024. PMID: 39227584 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous